Trajectory, interactions, and predictors of higher symptom burden during induction therapy for multiple myeloma

Trajectory, interactions, and predictors of higher symptom burden during induction therapy for multiple myeloma

Abstract Background Patients with multiple myeloma (MM) experience disabling symptoms that are difficult to manage and may persist after induction therapy. Monitoring disease-related and induction therapy–induced symptoms and identifying patients at greater risk for high symptom burden are unmet cli...

Full description

Bibliographic Details
Main Authors: Mona Kamal, Qiuling Shi, Shu-En Shen, Charles Cleeland, Xin Shelley Wang
Format: Article
Language:English
Published: SpringerOpen 2024-12-01
Series:Journal of Patient-Reported Outcomes
Subjects:
Symptom burden
Multiple myeloma
Induction therapy
Patient-reported outcomes (PROs)
Online Access:https://doi.org/10.1186/s41687-024-00817-6

Internet

https://doi.org/10.1186/s41687-024-00817-6

Similar Items